The epigenetic marker 5-hydroxymethylcytosine differentiated neuroblastoma risk group and outcomes. American Society Clinical Pharmacology and Therapeutics (ASCPT). (Poster presentation, top poster award)

Erin Barr; et al

The epigenetic marker 5-hydroxymethylcytosine differentiated neuroblastoma risk group and outcomes. American Society Clinical Pharmacology and Therapeutics (ASCPT). (Poster presentation, top poster award)

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	American English
Title of host publication	American Society Clinical Pharmacology and Therapeutics (ASCPT). (Poster presentation, top poster award)
State	Published - 2018

Cite this

@inproceedings{17a90bee441449c5a5e430c12653c5d1,

title = "The epigenetic marker 5-hydroxymethylcytosine differentiated neuroblastoma risk group and outcomes. American Society Clinical Pharmacology and Therapeutics (ASCPT). (Poster presentation, top poster award)",

author = "Erin Barr and et al",

year = "2018",

language = "American English",

booktitle = "American Society Clinical Pharmacology and Therapeutics (ASCPT). (Poster presentation, top poster award)",

}

The epigenetic marker 5-hydroxymethylcytosine differentiated neuroblastoma risk group and outcomes. American Society Clinical Pharmacology and Therapeutics (ASCPT). (Poster presentation, top poster award). / Barr, Erin; al, et.
American Society Clinical Pharmacology and Therapeutics (ASCPT). (Poster presentation, top poster award). 2018.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

TY - GEN

T1 - The epigenetic marker 5-hydroxymethylcytosine differentiated neuroblastoma risk group and outcomes. American Society Clinical Pharmacology and Therapeutics (ASCPT). (Poster presentation, top poster award)

AU - Barr, Erin

AU - al, et

PY - 2018

Y1 - 2018

M3 - Conference contribution

BT - American Society Clinical Pharmacology and Therapeutics (ASCPT). (Poster presentation, top poster award)

ER -